Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
13.52
+0.64 (4.97%)
At close: Sep 4, 2025, 4:00 PM
13.30
-0.22 (-1.63%)
After-hours: Sep 4, 2025, 4:24 PM EDT
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $1.66 billion as of September 4, 2025. Its market cap has increased by 145.20% in one year.
Market Cap
1.66B
Enterprise Value
1.62B
1-Year Change
145.20%
Ranking
Category
Stock Price
$13.52
Market Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $1.66B, an increase of 179.38%. That is a compound annual growth rate of 11.04%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 3, 2025 | 1.65B | -27.08% |
Dec 31, 2024 | 2.26B | 1,162.26% |
Dec 29, 2023 | 179.10M | -58.22% |
Dec 30, 2022 | 428.70M | -31.15% |
Dec 31, 2021 | 622.70M | -37.40% |
Dec 31, 2020 | 994.70M | 35.19% |
Dec 31, 2019 | 735.80M | 84.92% |
Dec 31, 2018 | 397.90M | -27.59% |
Dec 29, 2017 | 549.50M | 34.55% |
Dec 30, 2016 | 408.40M | -12.21% |
Dec 31, 2015 | 465.20M | -21.58% |
Nov 13, 2015 | 593.20M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 662.38B |
Johnson & Johnson | 428.68B |
AbbVie | 374.26B |
UnitedHealth Group | 278.84B |
AstraZeneca | 254.65B |
Novo Nordisk | 253.55B |
Novartis AG | 248.54B |
Abbott Laboratories | 230.05B |